Thursday, October 28, 2010 9:44:23 AM
SINO GREEN LAND CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2009 AND 2008
(UNAUDITED)
THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
2009 2008 2009 2008
(Restated) (Restated) (Restated) (Restated)
Sales $ 31,153,814 $ 27,656,309 $ 71,460,013 $ 57,667,879
Cost of goods sold 27,327,948 24,903,236 63,474,265 51,344,940
Gross profit 3,825,866 2,753,073 7,985,748 6,322,939
Operating expenses
Selling expenses 1,235,793 501,805 2,123,930 1,028,279
General and administrative expenses 529,818 144,077 1,839,298 879,194
Total operating expenses 1,765,611 645,882 3,963,228 1,907,473
Operating income 2,060,255 2,107,191 4,022,520 4,415,466
Other income(expense)
Interest expenses (income) (163,202 ) (7,909 ) (185,702 ) (24,559 )
Change in derivative liability (277,620 ) 172,305 (252,149 ) (91,015 )
Loss on debt extinguishment (139,289 ) (139,289 )
Others, net (2,194 ) 19,541 (2,122 ) 19,088
Total other income (expense) (582,305 ) 183,937 (579,262 ) (96,486 )
Net income 1,477,949 2,291,128 3,443,257 4,318,980
Other comprehensive income (loss)
Foreign currency translation gain (loss) 7,243 710,922 (159,985 ) 833,427
Comprehensive income $ 1,485,192 $ 3,002,050 $ 3,283,272 $ 5,152,407
Net income per share
Basic $ 0.01 $ 0.03 $ 0.04 $ 0.05
Diluted $ 0.01 $ 0.03 $ 0.03 $ 0.05
Weighted average number of shares outstanding
Basic 98,610,694 81,648,554 84,644,460 81,648,554
Diluted 125,388,131 81,648,554 111,515,489 81,648,554
Recent SGLA News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 11:54:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 10:10:45 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/12/2024 11:20:32 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 11:06:21 AM
- Form 10-KT - Transition reports [Rule 13a-10 or 15d-10] • Edgar (US Regulatory) • 09/28/2023 07:03:16 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/28/2023 03:55:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 10:52:40 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM